InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Monday, 06/03/2019 9:50:43 AM

Monday, June 03, 2019 9:50:43 AM

Post# of 418
News: $EYEG EyeGate Receives Approval from FDA to Initiate PRK Pivotal Study

WALTHAM, MA / ACCESSWIRE / June 3, 2019 / EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) ("EyeGate" or "the Company") announced today it has received approval from the U.S. Food and Drug Administration ("FDA") to initiate its photorefractive keratectomy ("PRK") pivotal study. The FDA has deter...

Find out more https://marketwirenews.com/news-releases/eyegate-receives-approval-from-fda-to-initiate-prk-pivotal-study-8287582.html
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.